:true:
The Power of Precision
false
us
ZenoTOF 7600 system
X500R system
X500B system
View all
SelexION device
SCIEX 7500 system
SCIEX Triple Quad 6500+ system
SCIEX 5500+ system
QTRAP 6500+ system
QTRAP 4500 system
Citrine system
4500MD system
Jasper system
View all mass spectrometers
Intabio ZT system
Echo MS system
Biologics Quant solution
Biotransform solution
MPX 2.0 High Throughput Multiplexing system
View all integrated solutions
BioPhase 8800 system
CESI 8000 Plus system
PA 800 Plus system
P/ACE MDQ Plus system
GenomeLab GeXP system
View all capillary electrophoresis
Advance your research with front-end instruments designed to help you realize the full power of your mass spectrometer. SCIEX has the broadest portfolio of ESI-MS front-ends that can facilitate various flow rates, sample requirements and sensitivities. No one else offers the entire range of analytical flow, microflow, nanoflow LC-MS and even ultra-low flow CESI-MS.
ExionLC 2.0 series
Micro HPLC columns
M5 MicroLC system
View All
Ultra-low Flow CESI-MS
View all front-end HPLC MS
Differential mobility spectrometry (DMS) and ion mobility spectrometry are analytical techniques used to separate ions based on their gas phase mobility. Multiple types of ion mobility devices exist, such as drift tubes, traveling wave, and high-field asymmetric waveform devices. Learn how you can separate yourself with Differential Ion Mobility.
The latest ion sources from SCIEX enable enhanced sensitivity and robustness with greater desolvation range across all MS platforms, from Triple Quad to QTRAP and QTOF.
Turbo V ion source
OptiFlow Turbo V ion source
OptiFlow Interface
View all ion sources
vMethod applications are pre-configured and verified LC-MS/MS methods that reduce the need for method development – significantly cutting the time, effort and money to deploy a new assay. Every vMethod provides method conditions, recommended sample prep, LC and MS conditions, and details for applicable MS/MS library databases for key applications.
AA45/20 1.0
aTRAQ
Illicit drugs
Acrylamide
Allergens
Antiobiotics/veterinary drugs
Cannabinoids
Illegal dyes
Melamine
Mycotoxins
Pesticides
Industrial chemicals (bisphenol)
Industrial chemicals (ethanolamines)
Pesticides (herbicides)
Pesticides (Polar)
Pharmaceutical and personal care products (PPCPs)
Peptide and protein bioanalysis
Routine biologics characterization
Benzodiazepines
Blood screening
Drugs of abuse
Etg and ets
Nicotine
THC-COOH
Urine screening
Explore vMethod applications
Software downloads
Software activation
Software support policy
Software support plans
Software feature request portal
Software partners
SCIEX OS software
Biologics Explorer software
Cliquid software
DiscoveryQuant software
Molecule Profiler software
OneOmics suite
View all software
High resolution and QTRAP libraries can dramatically enhance the quality of your analysis, giving you much improved confidence in your data. With a comprehensive library at your fingertips, you can easily create methods and process targeted and non-targeted screening data on your complex samples, faster and easier than ever before.
All in one library
SCIEX all-in-one HR-MS/MS library with NIST 2017
Antiobiotic Llbrary
Flurochemical library
Forensic library
Mycotoxin library
Natural products
Pesticide library
Wiley Libraries
Antibiotic library
Meta library
Explore the library selector tool
Boost the performance of your mass spectrometer and improve sensitivity, productivity, and data precision. iChemistry Solutions are the world's only reagents and consumables that are custom designed with your success in mind.
RNA 9000 Purity & Integrity kit
aTRAQ kit for amino acid analysis of hydrolysates
aTRAQ kit for amino acid analysis of physiological fluids
Protein CE-SDS Purity Analysis kit
MS calibration kits
CZE rapid charge variant analysis kit
BioPhase Fast Glycan Labeling and Analysis kit
iTRAQ reagent
mTRAQ reagent
View all consumables
QTOF – Quadrupole Time of Flight
QTRAP® – Triple Quad Linear Ion Trap
SWATH® – Data Independent Acquisition
SelexION® – Differential Mobility Separation
MicroLC – Microflow Chromatography
Ultra Low-Flow CESI-MS Technology
iCIEF-MS Technology
Nominal Mass LC-MS-MS
Acoustic Ejection Mass Spectrometry
View All Technology
ADME and DMPK
Biomarker quantitation
Cell therapy
CRISPR/Cas9 analysis
Viral vector characterization
Biomarker discovery
High-throughput mass spectrometry
Metabolite identification
Targeted protein degraders and PROTACs
Extractables and leachables
Pharma impurities
Residual nucleic acid analysis
Lipid nanoparticles and non-viral carrier
Messenger RNA analysis
Plasmid and DNA analysis
Synthetic oligonucleotide analysis
ADC analysis
Cell line analysis
Charge heterogeneity analysis
Glycan analysis
Intact protein analysis
Multi-attribute methodology
Peptide mapping analysis
Subunit mass analysis and middle-down
View all Biopharma and pharma
Clinical research
Clinical diagnostics
Clinical Mass Spec Operators
Clinical Method Developers
Clinical Lab Managers
View All Clinical
PFAS
Pesticides & herbicides
PPCP
Disinfection by-products
Soil and biota
Ethanolamine
Synthetic polymers
Exposome
Suspect screening
Nanomaterials
View All Environmental Testing
How do you protect your reputation and meet today’s global food safety standards? Whether you are a commercial lab or a food manufacturer, the quality of your food testing data is vital to your business. SCIEX solutions help you meet maximum residue limits (MRLs) with high-quality data that you can genuinely count upon. With a portfolio of applications, your lab can quickly and easily react to diverse market needs.
Pesticide Testing
Mycotoxins Testing
Antibiotics Testing
Potency Testing
Mycotoxin Testing
Terpenes Profiling
Meat Speciation Testing
Food Fraud Analysis
Food Adulterant Testing
Food Dye Testing
Food Omics
Allergen Testing
Ingredient Authenticity & Profiling Analysis
Packaging & Food Contact Substance Analysis
View All Food and Beverage Testing
How do you ensure the integrity of your results in an industry that is never constant? By accurately detecting even the smallest compound angles you can deliver evidence that stands. SCIEX forensic analysis solutions deliver fast, highly accurate data across a multitude of compounds and biomarkers, from the known to the new and novel.
Forensic toxicology
Homeland security (coming soon!)
Cannabis and hemp potency testing
Doping control
View All Forensic Testing
Discovery Proteomics
Next-Generation Proteomics
Targeted Proteomics
Untargeted Lipidomics
Targeted Lipidomics
Untargeted Metabolomics
Targeted Metabolomics
Metabolic Flux Analysis
Gene Expression Analysis
DNA Sequencing
Genotyping and SNP Analysis
STR Analysis
AFLPs
View All Life Science Research
The SCIEX Now Learning Hub offers the most diverse and flexible learning options available, with best-inclass content that helps you to get the most out of your instrument and take your lab to the next level. Available personalized learning paths based on the latest memory science ensure better knowledge retention, and automated onboarding and enrollment means you’ll get up and running faster.
SCIEX Now Learning Hub offers the most diverse and flexible learning options available, with best-in-class content that helps you to get the most out of your instrument and take your lab to the next level. Available personalized learning paths based on the latest memory science ensure better knowledge retention, and automated onboarding and enrollment means you’ll get up and running faster.
SCIEX Learning Manager provides you with the infrastructure to assign, monitor and report on your staff's competency through a single digital platform. Effectively manage the training process for new hires, ensure continuous staff development and access information with a single log-in to your SCIEX account.
You can browse, filter, or search our extensive list of training offerings. Choose from over 100 self-paced eLearnings or search for an instructor-led course near you. Once you select the course you want to take, you will be directed to Learning Hub for enrollment (login required).
Login to SCIEX Now Learning Hub
Success Programs at Your Site
Online Course Catalog
Clinical Knowledge Center
Application Scientist Training at Your Site
China
Europe
German CE Courses
India
Japan
Korea
North America
UK
Visit all Training
Support cases
SCIEX Now Learning Hub
Instruments
Manage my instruments
Registered software
Activate software
Resource library
My notifications
Request support
Course catalog
SCIEX Store
SCIEX Now New Feature Request
Visit your SCIEX Now™ Dashboard
Declaration of conformance
Safety data sheets
Certificates of analysis
View All regulatory documents
Customer documents
Software and IT services
Compliance services
Lab optimization
Customized training
Relocation services
LC-MS service plans
Protect Plus Suite for your new LC-MS
CE service plans
Clinical service plans
StatusScope remote monitoring
Software accelerator program
Premium access content
Academic partnership program
Academic partners
View all partnership programs
Join the SCIEX community today to interact with your peers, share and exchange ideas, develop your knowledge, stay up-to-date with the latest products, post insights and questions, comment on others and receive support. This community is designed to help you, our customers, move science forward and get the answers you need. We’re committed to engaging with and listening to you, to create the best customer experience possible and to contribute to the success of your work.
Biopharma
Clinical
Environmental / Industrial
Food and Beverage
Forensics
Life Science Research
Pharma
Technology
Knowledge Base Articles
Course Catalog
Software Downloads
Request Support
SCIEX Now Feature Requests
Software Feature Requests
Newsletter Archive
Featured Content
FAQs
View All Community
About SCIEX
About Danaher
Customer Profiles
Echo® MS Center Of Excellence
Our History
Our favorite papers
Meet our executives
Career opportunities
Contact us
Press releases
In the news
Awards
Sustainability
You've got questions. We've got experts who can help. Contact us to find out more, talk to a specialist, explore our solutions or get expert support.
Talk to a specialist
Request more information
Request a quote
SCIEX success network
Frequently asked questions
SCIEX community
Request hosted catalog
Request punchout
Global public relations
508-782-9484
Country/Region Canada Mexico United States
Country/Region Argentina Brazil Chile Colombia Costa Rica Ecuador El Salvador Guatemala Peru Uruguay Venezuela
Country/Region Germany Albania Austria Belgium Bosnia and Herzegovina Bulgaria Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Ireland Italy Latvia Lithuania Luxembourg Macedonia Montenegro Netherlands Norway Poland Portugal Romania Serbia Slovakia Slovenia Spain Sweden Switzerland United Kingdom
Country/Region Bangladesh Brunei Darussalam Cambodia 中国 Hong Kong India Indonesia 日本 한국 Singapore Sri Lanka Taiwan Thailand Viet Nam
Country/Region Bahrain Iran Iraq Israel Jordan Kuwait Lebanon Oman Pakistan Palestine Qatar Saudi Arabia Syria Turkey United Arab Emirates Yemen
Country/Region Algeria Angola Botswana Burundi Egypt Ethiopia Kenya Liberia Libya Morocco Rwanda South Africa Tunisia Uganda United Republic of Tanzania Zambia Zimbabwe
Country/Region Armenia Azerbaijan Belarus Georgia Kazakhstan Kyrgyzstan Moldova Russia Tajikistan Turkmenistan Ukraine Uzbekistan
Country/Region Australia Micronesia New Zealand
AB Sciex is doing business as SCIEX. © 2010-2018 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB SCIEX™ is being used under license. Beckman Coulter® is being used under license. Product(s) may not be available in all countries. For information on availability, please contact your local representative. For research use only. Not for use in diagnostic procedures.
Download tech note (PDF)
Resolve and identify endogenous compounds using the X500R QTOF system
Craig M. Butt,1 Robert A. Di Lorenzo,2 Casey Burrows,1 Frederick G. Strathmann,3 Joseph W. Homan3 1SCIEX, USA, 2SCIEX, Canada, 3NMS Labs, PA, USA
Co-eluting interferences in biological matrices have been shown for PFOS and PFHxS when monitoring the [SO3]- fragment ion. Here, accurate mass spectrometry was used to mass resolve PFOS & PFHxS from these interferences. The separation used was able to chromatographically resolve the interferences using a 6.5 minute gradient. The interferences were then characterized using their MS/MS fragmentation spectra and library searching.
Poly- and perfluorinated alkyl substances (PFAS) are well-known anthropogenic contaminants and are detected worldwide in most environmental media, including air, water and soil. Widespread human exposure has resulted in the nearly ubiquitous detection of PFAS in human serum.1,2 Accurate and robust analytical methods are needed to quantify the total PFAS burden in humans and to understand potential health risks.
PFAS serum analysis is challenging due to matrix complexity and potential endogenous interferences. Specifically, co-eluting interferences have been shown for perfluorooctane sulfonic acid (PFOS) and perfluorohexane sulfonate (PFHxS) when monitoring the [SO3]- fragment ion (m/z 80) during traditional MRM analysis.3 In this application note, a high resolution, high mass accuracy mass spectrometer was used to mass resolve PFOS and PFHxS from serum interferences. The interferences were characterized using their fragmentation patterns and through comparison with MS/MS libraries. Finally, the serum interferences were chromatographically resolved using a 6.5 min gradient (Figure 1).
Figure 1. Confirming chromatographic separation of PFOS interference. A wide XIC chromatogram (498.53–499.33 Da) for a pooled plasma/serum sample was generated from the TOF MS data (top panel) and multiple chromatographic peaks were observed. This wide extraction width simulates what would be isolated by Q1 in a typical MRM experiment. The precursors present in the TOF MS within the peaks at RT 3.299 and 3.394 (bottom left) and at RT 3.556 (bottom right) show the exact masses for 1) PFOS at m/z 498.9302, and to show that the major interference at m/z 498.2886 for 2) the plasma/serum matrix peak has been chromatographically resolved, and that they can easily be mass resolved by narrowing the XIC extraction width to a standard 20 mDa.
Sample preparation: Five pooled samples were prepared from discarded serum and plasma specimens. Samples (0.5 mL) were denatured using 2 mL of acetonitrile with 1% formic acid followed by centrifugation. The supernatant was passed through an Agilent Captiva EMR-lipid cartridge (300 mg), and the eluent was evaporated under a nitrogen stream and reconstituted in 200 µL of 1:1 water and methanol (1% formic acid).
Analytical standards: The EPA 533 PFAS list was selected as the target analytes. Analytical standards were purchased from Wellington Laboratories (Guelph, ON, Canada).
Chromatography: Chromatography was performed using the ExionLC system from SCIEX. Analytes were separated using a Phenomenex Gemini C18 (110 Å, 100 x 3 mm, 3 μm particle size) column using gradient conditions and a flow rate of 0.5 mL/min. The mobile phases were water (“A”) and methanol (“B”), both modified with 10 mM ammonium acetate. The column oven was 40ºC and the injection volume was 10 µL. Initial conditions were 20% “B” held for 1 min and then increased to 99% “B” over 3.5 min.
Mass spectrometry: Analysis was performed on the X500R QTOF system with the Turbo V ion source using an electrospray ionization (ESI) probe in negative ion mode. Data was collected using MRMHR acquisition mode with compound-specific, optimized parameters. The TOF MS scan ranged from 100 to 1,000 Da using DP = -50 V and CE = -5 V. The source and gas conditions were GS1 = 60, GS2 = 60, CUR = 35, CAD = 10, TEM = 500oC and ISV = -4500 V. Serum/plasma endogenous interferences were characterized through information dependent acquisition (IDA) mode using similar conditions.
Fluorine atoms have a negative mass defect (i.e., their exact mass is lower than their nominal mass, 19F = 18.9984 Da). Thus compounds that contain a high abundance of fluorine (e.g., PFAS) have lower precursor masses compared to compounds that are primarily hydrogen substituted (1H = 1.0078 Da), such as the plasma/serum endogenous interferences. Therefore, this investigation explored whether this mass defect could help differentiate PFAS compounds from non-fluorinated background ions. Also, it should be noted that monitoring the [SO3]- fragment ion (m/z 79.9574) can be challenging, as both the perfluorinated sulfonates (e.g., PFHxS and PFOS) and the endogenous interferences produce the same fragment ion during MS/MS analysis, reducing the specificity obtained in this mode.
The PFOS retention time (3.3–3.4 min) was confirmed by comparison to an authentic standard in solvent. Potential PFAS interferences in the serum/plasma were investigated by setting the TOF MS extracted ion chromatogram (XIC) extraction width to 0.8 Da (i.e., m/z 498.53–499.33 Da). The 0.8 Da extraction window was chosen to represent the interferences experienced at nominal mass resolution, similar to a triple quadrupole or QTRAP system. As shown in Figure 1, the wide TOF MS XIC showed several peaks adjacent to the branched and linear isomer PFOS cluster. This was unsurprising considering that PFOS endogenous interferences have been widely reported.3
The TOF MS spectrum under the PFOS peaks showed the predominance of the theoretical PFOS precursor ion (m/z 498.9302 Da) and very minor interference contribution. This demonstrates that the endogenous PFOS interferences were chromatographically resolved from the main PFOS cluster. In contrast, the TOF MS spectrum under the 3.6 min peak showed the m/z 498.2886 ion as the precursor molecular ion and the absence of the PFOS precursor ion. These results show the benefit of using the X500R QTOF system to mass resolve the potential interferences and, in this case, confirm that the major interference has been separated from the target compound. This is important because plasma and serum samples vary widely in composition, and chromatographic separation may not always be possible.
To identify the PFOS interference, an extended chromatographic gradient was used with IDA to obtain MS/MS fragmentation spectra (Figure 2). Library matching was performed against the NIST 2017 MS/MS library for structure elucidation. The MS/MS spectrum matched to several possible taurine-based cholic acids (Figure 2), as previously reported.4 Specifically, the MS/MS spectrum shows the presence of the [SO3]- fragment, demonstrating the benefits of using high-resolution mass spectrometry (HRMS) to resolve this interference from PFOS. In the case of multiple reaction monitoring (MRM) analysis, these 2 masses would have been extracted within the same Q1 isolation window and would exhibit the same fragment ion.
Figure 2. Identification of the PFOS interference from serum/plasma matrix. (Right) XIC of TDCA (C26H45NO6S) with TOF MS information below highlights the excellent mass accuracy (0.7 ppm) of the system. (Top right) MS/MS fragmentation spectrum zoomed from m/z 50–150 Da with table of library matches to taurine-based cholic acids below.
Similar to the investigation of PFOS plasma/serum interferences, the PFHxS retention time was confirmed by comparison to an authentic standard (2.7–2.8 min for the branched and linear isomer cluster). The plasma/serum PFHxS interferences were observed by setting a 0.8 Da XIC width (m/z 398.54–399.34 Da). Figure 3 shows the PFHxS peak at 2.8 min in a pooled plasma/serum sample, but also several potential interferences eluting after the PFHxS peak. The TOF MS spectrum under the PFHxS peak predominately shows the expected m/z 398.9366 Da precursor ion, which is consistent with the theoretical PFHxS ion. In contrast, the TOF MS spectrum under the 2.9 min peaks shows 2 main precursors at m/z 399.1853 Da and 399.2200 Da. These endogenous compounds were ~0.3 Da larger than the PFHxS precursor ion, demonstrating that the X500R QTOF system was capable of mass resolving the interferences and improving data quality through the reduction of false positives.
Figure 3. Confirming chromatographic separation of PFHxS interference. A wide XIC chromatogram (398.54–399.34 Da) for a pooled plasma/serum sample was generated from the TOF MS data (top panel) and multiple chromatographic peaks were observed. The precursor masses in the TOF MS spectrum within the peaks at RT 2.752 (bottom left) and at RT 2.874 and 2.937 (bottom right) show the minimal interferences present for 1) PFHxS at m/z 398.9366, and to show that the major interferences at m/z 399.1853 and 399.2209 for 2) plasma/serum matrix peaks have been chromatographically resolved, and that they can easily be mass resolved by narrowing the XIC extraction width to a standard 20 mDa.
The endogenous PFHxS interferences were further interrogated by extending the chromatographic gradient and acquiring MS/MS fragmentation spectra using IDA (Figure 4). The main interference peak at m/z 399.2209 Da was detected at 6.2 min, and the formula finder in SCIEX OS software identified the formula as C21H36O5S (mass error = 0.0 ppm, isotope ratio difference = 2.2%). The MS/MS fragmentation pattern contained the [HSO3]- ion but did not have a confirmed library match, so the exact structure is unknown.
Figure 4. PFHxS interference from serum/plasma matrix. XIC of the main PFHxS plasma/serum interference at m/z 399.2209 Da and the MS/MS fragmentation spectrum is shown. No reasonable library match was obtained, so identity is unknown.
XICs were generated again using narrow extraction windows to highlight the advantages of using higher-resolution platforms to characterize a sample in comparison to traditional MRM-based workflows.5 Figure 5 shows the PFHxS and PFOS XICs resulting from a narrow 20 mDa XIC extraction width. Compared to Figure 1 and Figure 3, this clearly shows the benefits of using the X500R QTOF system for PFAS analysis in biological tissues. It has the ability to mass resolve the PFAS analytes from endogenous interferences, thereby reducing false positives and improving data quality.
Figure 5. High-resolution extraction of TOF MS data. PFHxS and PFOS chromatograms using a 20 mDa XIC width from TOF MS data for a pooled plasma/serum sample. Endogenous interferences are different enough in mass to be outside of the narrow 20 mDa XIC width, thereby removing the interferences from the PFAS signal.
Here, the ability to use the negative mass defect of the heavily fluorinated PFAS compounds to differentiate these target compounds for endogenous compounds was explored. Using PFOS and PFHxS as examples, narrow width XICs of the precursor mass enabled the compounds to be clearly differentiated from the background ions, demonstrating that the X500R QTOF system had sufficient resolving power to separate. Using optimized chromatography, the background ions were separated from the target analytes and full scan MS/MS was acquired to try and identify the endogenous compounds. The PFOS interference was found to likely be taurine-based cholic acids while the PFHxS did not produce a library match.